Oroidin derived, pyrrole imidazole marine alkaloids (PIAs) are attractive targets for synthetic organic chemists because of their structural complexity and diversity, as well as their interesting biological activities. A number of efforts have been carried out to develop strategies for the synthesis of these natural products. Members of PIAs (eg., 2-7) , which contain tetracyclic ring systems possessing characteristic cyclic guanidine or urea moieties, show significant biological activities including anticancer activity and agonistic activity against the adrenoceptor. In this review, investigations of the total synthesis of the representative tetracyclic PIAs, dibromophakellin (2) and dibromophakellstatin (3), are described.
Tetracyclic pyrrole imidazole alkaloids (PIAs) (2-9, Figure 1 ) are members of the oroidin-derived marine alkaloid family, which have been isolated for the most part from marine sponges. These structurally diverse alkaloids, which possess compact and complex structures [1a-c] , show significant biological activities such as antitumor activity and agonistic activity against the adrenoceptor [1d] . Their structural features together with their biological activities have prompted synthetic chemists to devise strategies for the total synthesis of members of this class of alkaloids. Recently, the results of several synthetic studies and investigations leading to the total synthesis of the PIAs have been reported [1b,c] . In this review, recent efforts aimed at the total synthesis of the tetracyclic PIAs, dibromophakellin (2) and dibromophakellstatin (3), are described. The biosynthetic pathway for the tetracyclic PIAs from oroidin (1) is proposed to begin with proton mediated isomerization of the 2-amino-4-vinylimidazole moiety in 1, followed by two sequential cyclizations involving intramolecular addition of the pyrrole unit to C6 and addition of N14 to C10 (Scheme 1) [1a-c, 2] . Several strategies for the synthesis of tetracyclic PIAs have followed designs that are inspired by this biosynthesis hypothesis and in which a major focus has been given to the efficient construction of the characteristic N,N-aminal structural unit at C6 and C10 in either the cyclic guanidine or urea moieties of the targets.
A route for construction of the tetracyclic PIA core following a biomimetic strategy, which involves oxidation of the guanidineimidazole unit in dihydrooroidin (10), followed by base mediated cyclization (11→2), was described by Foley and Büchi in 1982 (Scheme 2) [3] . In the pathway, the guanidine-imidazole moiety in 10 was oxidized using bromine in acetic acid, producing intermediate 11 that underwent cyclization to generate (±)dibromophakellin (2) when treated with potassium t-butoxide. A similar approach was developed by Wiese and coworkers. In this pathway, N-bromosuccinimide in TFA and triethylamine were employed as the respective oxidants and base [4] . These conditions were also employed to accomplish transformation of the cyclic urea 12 to dibromophakellstatin (3) (Scheme 3) [4] . Stang's reagent (PhI(CN)OTf). Cyclization of 14 occurred spontaneously via a Pummerer-type reaction to produce 15. Finally, oxidative removal of the thiophenyl group in 15 using CAN generated (±)-dibromophakellstatin (3), which upon guanylation was transformed to (±)-dibromophakellin (2). Construction of N,N-aminal moieties at the C6 and C10 quaternary centers in tetracyclic PIAs is perhaps the most challenging issue confronting the synthesis of members of this family. One strategy that has been devised to address this issue utilizes a sequential electrophile nucleophile addition process. In this approach, an electrophile reacts with the enamide moiety in 16 to produce an iminium ion intermediate 17, which then undergoes addition of a nucleophile to generate 18 that contains the desired substitution pattern at C6 and C10 (Scheme 5).
Scheme 5: Sequential electrophile-nucleophile addition approach for synthesis of PIAs.
This general strategy was utilized by Jacquot and coworkers to synthesize (±)-dibromophakellstatin (3) through a route in which the key tricyclic enamide intermediate 16a was readily prepared from prolinol 19 and pyrrole carboxylic acid derivative 20a (Scheme 6) [6] . In the key step in this pathway, ethyl N-tosyloxycarbamate 21 was used as both the electrophile and nucleophile. Accordingly, electrophilic addition of 21 to C6 of enamide 16a with concurrent loss of the tosylate generated a N-acyliminium ion intermediate that then is trapped at C10 by nucleophilic addition of 21. The bis-carbamate formed in this manner spontaneously cyclizes to give cyclic urea 23, which served as a late stage intermediate in the route to (±)-3.
Austin and coworkers have taken advantage of the combined electrophilic and nucleophilic nature of the azide ion in an approach for the preparation of this same target.
In the pathway, stereoselective cis-diazidation reaction between enamide 16b and tetraethylammonium iodide diazide (24) gave the bis-azide 25 that was converted to cyclic thiourea 26, which served as a late stage Scheme 6: Sequential electrophile-nucleophile addition approach for the synthesis of (±)-2 and (±)-3.
intermediate in the route to (±)-dibromophakellstatin (3) [7] . Employing a closely related sequential electrophile nucleophile addition strategy, Hewlett and Tepe were able to construct the tricyclic guanidine intermediate 28 directly by reaction of bromoenamide 16a with N-Boc guanidine (27) in the presence of Nbromosuccinimide [8] . This sequential process served as a key step in the preparation of (±)-dibromophakellin (2) .
Although the biomimetic and sequential electrophile nucleophile addition approaches for construction of the tricyclic N,N-aminal core structure of the PIAs are highly efficient, they are not readily applicable to routes for nonracemic synthesis of the targets. As a result, other approaches have been designed to prepare optically active forms of the PIAs. For example, Poullennec and Romo devised a procedure for construction of the nonraceimic N,N-aminal intermediate 35 as part of a synthesis of (+)-dibromophakellstatin (3) (Scheme 7) [9] . A key desymmetrization reaction in this sequence was performed to transform the symmetrical optically active diketopiperazine 30 to the C10 benzylformate intermediate 31. Oxidative conversion of the pyrrolidine moiety in 31 to the pyrrole in 32, followed by stereoselective installation of the amine at C6 then provided the bis-aminal 33. Upon being subjected to Hoffman rearrangement reaction conditions using PhI(O 2 CCF 3 ) 2 , 33 was converted to optically active cyclic urea 35, which served as a late stage intermediate in the route to (+)-(3). Scheme 7: Synthesis of (+)-3 by Poullennec and Romo [9] Wang and Romo also developed another strategy for construction of the key N,N-aminal structural unit in the PIAs in an optically active Total synthesis of pyrrole-imidazole alkaloids Natural Product Communications Vol. 8 (7) 2013 963 form (Scheme 8) [10] . In this approach, the absolute stereochemistry at C6 is governed by the preexisting configuration at C10 derived from L-prolinol (19), which was used as the starting material. In the pathway, tricyclic aminal 37, generated by reaction of 19 with pyrrole 20b, was subjected to base mediated isomerization conditions to give aminal 39 stereoselectively. In this process, the absolute configuration at C6 is governed by equilibrium controlled formation of the equatorial C6-amino diastereomer. Following formation of a guanidine group at C6, the product 41 was cyclized to form tetracyclic guanidine 44 by treatment with PhI(OAc) 2 . In this process, PhI(OAc) 2 promoted oxidation at C10 occurs to generate the iminium ion 43, which undergoes cyclization by addition of the guanidine moiety to provide 44, which serves as a precursor of (+)-dibromophakellin (2). Our group has recently developed a novel method for enantiocontrolled preparation of C10 N,N-aminals in tetracyclic PIAs as part of investigations aimed at the synthesis of (+)-2 and (+)-3 (Scheme 9) [11]. Our approach took advantage of an Overman rearrangement reaction to construct the C10 N,N-aminal moiety with stereochemical control being offered by a preexisting chiral allylic alcohol center in intermediate 48. The allylic alcohol containing diketopiperazine 48 was synthesized by a nine step sequence involving reaction of the optically active hydroxyproline 45 with pyrrole carboxylic acid 46 followed by reduction and acetylation.
Treatment of allylic alcohol 48 with trichloroacetonitrile and DBU generated the transient trichloroimidate that underwent Overman rearrangement to yield aminal 50 in a highly stereoselective manner. Although the Overman reaction usually requires high temperatures, we observed that the conversion of 48 to 50 takes place even at room temperature, a phenomenon that we attribute to rate acceleration provided by the electron donating nature of the electron rich enamide group in 49. Aminal 50 serves as an ideal intermediate in routes for the synthesis of both (+)-2 and (+)-3. Accordingly, 50 was converted to amine 51 by utilizing a four step sequence. Installation of the guanidine group at C10 in 53 followed by a cyclization reaction gave the tetracyclic guanidine 54, which was transformed to optically active (+)-dibromophakellin (2) . (+)-Dibromophakellstatin (3) was also prepared from amine 51. The requisite pseudourea functional group was installed by reaction of 51 with N-Cbz-isothiocyante (55) and methyliodide to give 56, which then underwent cyclization to generate the cyclic pseudourea 5, which was converted to (+)-3. Above, we have summarized the results of recent investigations that have led to novel syntheses of members of the tetracyclic PIA family. Owing to the fact that the numbers of new PIA congeners, including dimeric forms, are growing, these substances continue to represent challenging targets for synthetic organic chemists. Moreover, new strategies for the preparation of PIAs should aid in clarifying their biological activities and modes of action. 
